| Bioactivity | CpCDPK1/TgCDPK1-IN-3 (Compound 20) is a CpCDPK1 and TgCDPK1 inhibitor with IC50 values of 0.003 and 0.0036 µM, respectively. CpCDPK1/TgCDPK1-IN-3 can be used in the research of apicomplexan protozoa-related diseases, such as the research of T. gondii, C. parvum and C. hominus infection[1]. |
| Target | Apicomplexan protozoa. |
| Name | CpCDPK1/TgCDPK1-IN-3 |
| CAS | 1092788-87-8 |
| Formula | C17H18N6 |
| Molar Mass | 306.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. US20130018040A1. |
CpCDPK1/TgCDPK1-IN-3
CAS: 1092788-87-8 F: C17H18N6 W: 306.37
CpCDPK1/TgCDPK1-IN-3 (Compound 20) is a CpCDPK1 and TgCDPK1 inhibitor with IC50 values of 0.003 and 0.0036 µM, respecti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.